Market Cap 1.41B
Revenue (ttm) 673.00M
Net Income (ttm) -575.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -85.44%
Debt to Equity Ratio 0.00
Volume 3,253,600
Avg Vol 2,975,890
Day's Range N/A - N/A
Shares Out 98.59M
Stochastic %K 4%
Beta 0.31
Analysts Sell
Price Target $25.95

Company Profile

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevi...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 483 8800
Address:
60 Leveroni Court, Novato, United States
Isarheml
Isarheml Sep. 13 at 4:09 PM
$RARE you should delete your mom. With current burnrste is 10-12 month. Now they will be profitable next year so no.
0 · Reply
sica1983
sica1983 Sep. 13 at 3:12 PM
$RARE if you never won the lottery this is your chance. A $500-$1,000 bet this week could make you tens of thousands. $17.5 calls for this week expiry are trading for $10, this has a very high chance to hit 10-30x. Approval due September 19 but probably will by announced by Friday 18. RARE is not a very popular stock among traders and most traders on X never even heard of it so market makers have no interest to manipulate the price in order to punish the options gamblers. 100% own by institutions so if approval happens this goes above $20 very easy, if not probably wil stay around $14 -$15 for a longer time. You saw those big block of puts for October, those are just hedges of the institutions positioning ahed of the FDA decision . Stock price is very depressed and already priced in the worst of the outcome, most capitulated already on this trade. Even for the long term this is a good buy with asymmetric risk. You buy the fear, this company makes almost $1 billion yearly.
0 · Reply
rong22003
rong22003 Sep. 13 at 3:04 PM
$RARE should just delete your account if you do not want to lose money. Running around calling other retard? They burnt 300 mlns $ in hard cash in 6 months or 50$ mln per month and only got 140$. Right now they probably has 50$ mln in their bank.
0 · Reply
Idontknownothing55
Idontknownothing55 Sep. 13 at 10:45 AM
$RARE https://www.facebook.com/story.php?story_fbid=1504897878336498&id=SavingSadieRae
0 · Reply
Isarheml
Isarheml Sep. 13 at 5:31 AM
$RARE Cash & Reserves: As of mid-2026, Ultragenyx held approximately $436 million in cash, cash equivalents, and marketable securities. Retarded 🤡
2 · Reply
rong22003
rong22003 Sep. 13 at 5:21 AM
$RARE company will need cash soon. Dilution news will hit the main stream soon.
1 · Reply
AlbertAFT
AlbertAFT Sep. 13 at 12:50 AM
$RARE I found this online. It looks like it's going to go over $35 this week.
0 · Reply
Idontknownothing55
Idontknownothing55 Sep. 12 at 11:01 PM
$RARE The FDA has a busy month so it might postpone FDA decision on UX111 approval for the following week. I'm hoping we get it before the 19th so I'm not saying this is 100% but it's possible.
0 · Reply
AlbertAFT
AlbertAFT Sep. 12 at 8:08 PM
$RARE I made a chart showing when the short squeeze will kick-in as the price rises.
0 · Reply
Steve_TheBull_Rogers
Steve_TheBull_Rogers Sep. 12 at 7:57 PM
$RARE Some really weird tape going on the options here Those 25P are not in the updated OI meaning someone bought them then sold them. I take some whale is trying to cause a panic
3 · Reply
Latest News on RARE
Ultragenyx price target lowered to $32 from $43 at Barclays

2026-09-04T09:45:20.000Z - 9 days ago

Ultragenyx price target lowered to $32 from $43 at Barclays


Ultragenyx falls -44.0%

2026-09-03T16:05:40.000Z - 10 days ago

Ultragenyx falls -44.0%


Ultragenyx falls -44.6%

2026-09-03T14:00:13.000Z - 10 days ago

Ultragenyx falls -44.6%


Ultragenyx downgraded to Neutral from Buy at BofA

2026-09-03T13:45:12.000Z - 10 days ago

Ultragenyx downgraded to Neutral from Buy at BofA


Why Is Ultragenyx Pharmaceutical Stock (RARE) Down Today?

2026-09-03T13:29:30.000Z - 10 days ago

Why Is Ultragenyx Pharmaceutical Stock (RARE) Down Today?


Ultragenyx price target lowered to $28 from $77 at Jefferies

2026-09-03T12:56:13.000Z - 10 days ago

Ultragenyx price target lowered to $28 from $77 at Jefferies


Ultragenyx price target lowered to $18 from $49 at TD Cowen

2026-09-03T12:41:08.000Z - 10 days ago

Ultragenyx price target lowered to $18 from $49 at TD Cowen


Ultragenyx price target lowered to $23 from $30 at Wedbush

2026-09-03T12:10:56.000Z - 10 days ago

Ultragenyx price target lowered to $23 from $30 at Wedbush


Ultragenyx price target lowered to $37 from $83 at Canaccord

2026-09-03T10:55:10.000Z - 10 days ago

Ultragenyx price target lowered to $37 from $83 at Canaccord


Ultragenyx price target lowered to $28 from $58 at Citi

2026-09-03T10:31:03.000Z - 10 days ago

Ultragenyx price target lowered to $28 from $58 at Citi


Ultragenyx Pharmaceutical Transcript: Status update

Aug 19, 2026, 7:00 AM EDT - 25 days ago

Ultragenyx Pharmaceutical Transcript: Status update


Ultragenyx Pharmaceutical Press release: Status update

Aug 19, 2026, 7:00 AM EDT - 25 days ago

Ultragenyx Pharmaceutical Press release: Status update


Ultragenyx Pharmaceutical Earnings Call Transcript: Q2 2026

Aug 4, 2026, 5:00 PM EDT - 5 weeks ago

Ultragenyx Pharmaceutical Earnings Call Transcript: Q2 2026


Ultragenyx Pharmaceutical Earnings release: Q2 2026

Aug 4, 2026, 5:00 PM EDT - 5 weeks ago

Ultragenyx Pharmaceutical Earnings release: Q2 2026


Ultragenyx Pharmaceutical Quarterly report: Q2 2026

Aug 4, 2026, 5:00 PM EDT - 5 weeks ago

Ultragenyx Pharmaceutical Quarterly report: Q2 2026


Ultragenyx Pharmaceutical Transcript: AGM 2026

May 14, 2026, 11:30 AM EDT - 4 months ago

Ultragenyx Pharmaceutical Transcript: AGM 2026


Ultragenyx Pharmaceutical Earnings Call Transcript: Q1 2026

May 5, 2026, 5:00 PM EDT - 4 months ago

Ultragenyx Pharmaceutical Earnings Call Transcript: Q1 2026


Ultragenyx Pharmaceutical Earnings release: Q1 2026

May 5, 2026, 5:00 PM EDT - 4 months ago

Ultragenyx Pharmaceutical Earnings release: Q1 2026


Ultragenyx Pharmaceutical Quarterly report: Q1 2026

May 5, 2026, 5:00 PM EDT - 4 months ago

Ultragenyx Pharmaceutical Quarterly report: Q1 2026


Ultragenyx Pharmaceutical Slides: Corporate presentation

May 5, 2026, 7:00 AM EDT - 4 months ago

Ultragenyx Pharmaceutical Slides: Corporate presentation


Ultragenyx Pharmaceutical Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Ultragenyx Pharmaceutical Proxy statement: Proxy filing


Ultragenyx Pharmaceutical Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Ultragenyx Pharmaceutical Proxy statement: Proxy filing


Ultragenyx Pharmaceutical Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Ultragenyx Pharmaceutical Proxy statement: Proxy filing


Ultragenyx to Participate at Investor Conferences in March

Feb 23, 2026, 4:30 PM EST - 6 months ago

Ultragenyx to Participate at Investor Conferences in March


Ultragenyx Pharmaceutical Earnings Call Transcript: Q4 2025

Feb 12, 2026, 5:00 PM EST - 7 months ago

Ultragenyx Pharmaceutical Earnings Call Transcript: Q4 2025


Ultragenyx Pharmaceutical Annual report: Q4 2025

Feb 12, 2026, 5:00 PM EST - 7 months ago

Ultragenyx Pharmaceutical Annual report: Q4 2025


Ultragenyx Pharmaceutical Earnings release: Q4 2025

Feb 12, 2026, 5:00 PM EST - 7 months ago

Ultragenyx Pharmaceutical Earnings release: Q4 2025


Ultragenyx Pharmaceutical Slides: Corporate presentation

Feb 12, 2026, 7:00 AM EST - 7 months ago

Ultragenyx Pharmaceutical Slides: Corporate presentation


Ultragenyx Pharmaceutical Slides: Corporate presentation

Jan 10, 2026, 7:00 AM EST - 8 months ago

Ultragenyx Pharmaceutical Slides: Corporate presentation


Isarheml
Isarheml Sep. 13 at 4:09 PM
$RARE you should delete your mom. With current burnrste is 10-12 month. Now they will be profitable next year so no.
0 · Reply
sica1983
sica1983 Sep. 13 at 3:12 PM
$RARE if you never won the lottery this is your chance. A $500-$1,000 bet this week could make you tens of thousands. $17.5 calls for this week expiry are trading for $10, this has a very high chance to hit 10-30x. Approval due September 19 but probably will by announced by Friday 18. RARE is not a very popular stock among traders and most traders on X never even heard of it so market makers have no interest to manipulate the price in order to punish the options gamblers. 100% own by institutions so if approval happens this goes above $20 very easy, if not probably wil stay around $14 -$15 for a longer time. You saw those big block of puts for October, those are just hedges of the institutions positioning ahed of the FDA decision . Stock price is very depressed and already priced in the worst of the outcome, most capitulated already on this trade. Even for the long term this is a good buy with asymmetric risk. You buy the fear, this company makes almost $1 billion yearly.
0 · Reply
rong22003
rong22003 Sep. 13 at 3:04 PM
$RARE should just delete your account if you do not want to lose money. Running around calling other retard? They burnt 300 mlns $ in hard cash in 6 months or 50$ mln per month and only got 140$. Right now they probably has 50$ mln in their bank.
0 · Reply
Idontknownothing55
Idontknownothing55 Sep. 13 at 10:45 AM
$RARE https://www.facebook.com/story.php?story_fbid=1504897878336498&id=SavingSadieRae
0 · Reply
Isarheml
Isarheml Sep. 13 at 5:31 AM
$RARE Cash & Reserves: As of mid-2026, Ultragenyx held approximately $436 million in cash, cash equivalents, and marketable securities. Retarded 🤡
2 · Reply
rong22003
rong22003 Sep. 13 at 5:21 AM
$RARE company will need cash soon. Dilution news will hit the main stream soon.
1 · Reply
AlbertAFT
AlbertAFT Sep. 13 at 12:50 AM
$RARE I found this online. It looks like it's going to go over $35 this week.
0 · Reply
Idontknownothing55
Idontknownothing55 Sep. 12 at 11:01 PM
$RARE The FDA has a busy month so it might postpone FDA decision on UX111 approval for the following week. I'm hoping we get it before the 19th so I'm not saying this is 100% but it's possible.
0 · Reply
AlbertAFT
AlbertAFT Sep. 12 at 8:08 PM
$RARE I made a chart showing when the short squeeze will kick-in as the price rises.
0 · Reply
Steve_TheBull_Rogers
Steve_TheBull_Rogers Sep. 12 at 7:57 PM
$RARE Some really weird tape going on the options here Those 25P are not in the updated OI meaning someone bought them then sold them. I take some whale is trying to cause a panic
3 · Reply
knowthyself
knowthyself Sep. 12 at 7:15 PM
$RARE Everyone knows, I take it, that the facility in question in the CRL had another $RARE drug approved in August. I'd say the chances of approval are very high. FDA had no problem with the drug itself.
0 · Reply
Merlintrader
Merlintrader Sep. 12 at 5:13 PM
$AGIO $RARE $SRRK $SMMT — Top Ten Biotech Stocks Right Now: the names leading the current Merlintrader ranking https://www.merlintrader.com/top-ten-biotech-stocks-right-now/
0 · Reply
DorianMD
DorianMD Sep. 12 at 2:44 PM
$RARE chances of PDUFA approval????
3 · Reply
Michael675
Michael675 Sep. 12 at 2:01 PM
$RARE $ALMS Have a relaxing weekend, executives of the board(s)...and if you can't zone out even with sound knowledge of extremely high institutional ownership, jump on a flight to Scotland where I'll pitch you the next big thing- already making a return! 😆
0 · Reply
Stockseeking
Stockseeking Sep. 12 at 1:55 PM
$RARE I am going to hold my shares for a long haul. 4 approved products with increasing rev. Another one will be approved next week. You can look at the history of the approval rate upon resubmission due to CRL with solely CMC issue, which is >90%. In addition, they will get the rare disease voucher with a value of >150 millions.
0 · Reply
tedevan
tedevan Sep. 12 at 5:02 AM
1 · Reply
tedevan
tedevan Sep. 12 at 4:59 AM
0 · Reply
Stockseeking
Stockseeking Sep. 12 at 12:05 AM
$RARE Approval rate upon resubmission due to CMC issues is very high
1 · Reply
Idontknownothing55
Idontknownothing55 Sep. 11 at 9:29 PM
$RARE TLX FDA decision is today but still no news yet. Totally different product but they also had crl on their first try like we did. Let's hope ours comes before the 19th.
0 · Reply
OnlyBioLover
OnlyBioLover Sep. 11 at 8:44 PM
$RARE holding up fine into next week. the 19th is a saturday, fda doesn’t act on weekends, so realistically we hear wednesday to friday, and genglycos came four days early. on sell the news, that needs a run up into the date to create the sellers. this one fell 47% into it instead. nobody long from 26 is dumping at 16, and everyone long from 14 came for the catalyst. that’s the reverse setup. the part people underestimate is what happens the day the risk clears. a lot of institutional money can’t hold through a binary by mandate, so it sits out until the answer is in and then comes back all at once. and analysts who cut to neutral with a crl scenario in the model don’t stay neutral once that scenario is gone. the stock is trading below even the bear targets right now. that’s not priced in, that’s room. not advice.
1 · Reply
anvesti
anvesti Sep. 11 at 7:35 PM
Anvesti opened a long position $RARE · Entry $14.36 Model: ml_model_v3 · Score: 73.1
0 · Reply
usedgum
usedgum Sep. 11 at 6:51 PM
$RARE she’s definitely a fan. Therefore. I dig it.
0 · Reply